Skip to main content
Premium Trial:

Request an Annual Quote

Exelixis Names New Chief Medical Officer

NEW YORK, July 31 – Exelixis of South San Francisco, Calif., has appointed Jeffrey Latts chief medical officer and senior vice president for clinical development.

The appointment comes as part of Exelixis plans to step up its drug discovery efforts and advances a newly acquired drug through clinical trials.

"Jeff’s extensive experience in designing and implementing early- through late-stage clinical trials for cancer and other diseases adds an important component to Exelixis’ aggressive plans for product development," George Scangos, Exelixis’ CEO, said in a statement.

"His experience will be invaluable in achieving smooth integration of the clinical development of our new phase I/II rebeccamycin analogue and in the rapid advancement of our proprietary programs that are nearing the development stage," said Scangos, referring to the cancer drug the company recently acquired from Bristol-Myers Squibb.

As part of that deal, Exelixis and Bristol-Myers Squibb also agreed to work together to develop cancer drugs that target cells with defective tumor suppressor gene pathways.

Latts previously worked as vice president of clinical research and development and corporate chief medical officer at Berlex Laboratories. He has also worked as an executive in charge of clinical research at Wyeth Ayerst.

Exelixis has developed tools for understanding gene function based on comparative genomics and model system genetics.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.